Resolution of late-onset asthma following high-dose chemotherapy.
We describe a patient with moderately severe (British Thorax Society Step IV/V) asthma requiring regular inhaled and oral corticosteroids to control symptoms who experienced resolution of her asthma following high-dose chemotherapy and autologous stem cell transplantation for breast cancer. As far as the authors are aware this is the first reported case.
Palmieri
C
C
Department of Medical Oncology, Charing Cross Hospital, Fulham Palace Road, London, UK. c.palmieri@ic.ac.uk
Gillmore
R
R
Menzies-Gow
A
A
Fishpool
S
S
Robinson
D
D
Shaw
R
R
Coombes
R C
RC
D000903:Antibiotics, Antineoplastic / Q000009:adverse effects; D000963:Antimetabolites / Q000009:adverse effects; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001249:Asthma / Q000139:chemically induced*; D016026:Bone Marrow Transplantation; D001943:Breast Neoplasms / Q000628:therapy*; D003520:Cyclophosphamide / Q000009:adverse effects; D015251:Epirubicin / Q000009:adverse effects; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008875:Middle Aged
D000903:Antibiotics, Antineoplastic; D000963:Antimetabolites; D018906:Antineoplastic Agents, Alkylating; D015251:Epirubicin; D003520:Cyclophosphamide; D005472:Fluorouracil